mark j c nuijten
Ars Accessus Medica (a2m)
Amsterdam, Netherlands
Associate Editor
Pharmaceutical Medicine and Outcomes Research
Ars Accessus Medica (a2m)
Amsterdam, Netherlands
Associate Editor
Pharmaceutical Medicine and Outcomes Research
Janssen Pharmaceutica NV
Beerse, Belgium
Associate Editor
Pharmaceutical Medicine and Outcomes Research
University of Murcia
Murcia, Spain
Associate Editor
Neuropharmacology
University Hospital and Faculty of Medicine, University of TĂĽbingen
TĂĽbingen, Germany
Associate Editor
Predictive Toxicology
University at Buffalo
Buffalo, United States
Associate Editor
Neuropharmacology
George Washington University
Washington, D.C., United States
Associate Editor
Pharmacogenetics and Pharmacogenomics
University of Minnesota Health Sciences, University of Minnesota Medical Center
Minneapolis, United States
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
Lokman Hekim University
Ankara, TĂĽrkiye
Associate Editor
Ethnopharmacology
Complutense University of Madrid
Madrid, Spain
Associate Editor
Neuropharmacology
Miguel Hernández University of Elche
Elche, Spain
Associate Editor
Ethnopharmacology
Lagos State University
Ojo, Nigeria
Associate Editor
Pharmaceutical Medicine and Outcomes Research
Osaka Medical and Pharmaceutical Unive
Osaka, Japan
Associate Editor
Neuropharmacology
SĂŁo Paulo State University
SĂŁo Paulo, Brazil
Associate Editor
Integrative and Regenerative Pharmacology
Newcastle University
Newcastle upon Tyne, United Kingdom
Associate Editor
Ethnopharmacology
Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University
Sanda, Japan
Associate Editor
Pharmacology of Ion Channels and Channelopathies
University of Nairobi
Nairobi, Kenya
Associate Editor
Drugs Outcomes Research and Policies